Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis
Risk for postoperative eKA slightly increased; lower risks seen for perioperative acute kidney injury and 30-day mortality
Ubrogepant During Prodromal Phase of Migraine Eases Symptoms
Ubrogepant may treat prodromal symptoms, including photophobia, fatigue, phonophobia, cognitive dysfunction from as early as one hour
Mepolizumab Yields Lower Rate of Moderate/Severe Exacerbations in COPD
Time to first moderate or severe exacerbation longer with mepolizumab in patients with COPD, history of exacerbations, eosinophil count ≥300 cells/µL
Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer
Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors
BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuberculosis Infection
Adverse events occurred more often in the BCG revaccination group, and most were due to injection-site reactions
GLP-1 Receptor Agonists Reduce Alcohol Intake in Patients Treated for Obesity
Reductions in alcohol intake noted in high and low consumers; no significant difference seen in percentage reductions for men and women
FDA Approves At-Home Cervical Cancer Test for Women Ages 25 to 65
President Signs Executive Order to Lower Some Drug Costs
Order expected to affect specific medications covered under Medicare that are administered in a health care setting
No Causal Link Seen Between Stimulant Prescription, Psychotic Experience
No evidence observed for causal effect of stimulant prescription on subsequent psychotic experiences when applying doubly robust estimation
Intraocular Inflammation More Common With Aflibercept Injections in Real-World Setting
Findings seen for patients being treated for neovascular age-related macular degeneration or diabetic macular edema
